Page 84 - Read Online

Annibali et al. Mini-invasive Surg 2022;6:12 https://dx.doi.org/10.20517/2574-1225.2021.101 Page 13 of 16

long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of
Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European
Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2017;38:3382-90. DOI
6. Généreux P, Piazza N, Alu MC, et al; VARC-3 Writing Committee. Valve academic research consortium 3: updated endpoint
definitions for aortic valve clinical research. J Am Coll Cardiol 2021;77:2717-46. DOI PubMed
7. Otto CM, Nishimura RA, Bonow RO, et al; Writing Committee Members. 2020 ACC/AHA Guideline for the management of patients
with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint
Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;77:450-500. DOI PubMed
8. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention
2022;17:e1126-96. DOI PubMed
9. Sá MPBO, Van den Eynde J, Simonato M, et al. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve
replacement: an updated meta-analysis. JACC Cardiovasc Interv 2021;14:211-20. DOI PubMed
10. Thandra A, Abusnina W, Jhand A, et al. Valve-in-valve transcatheter aortic valve replacement versus redo surgical valve replacement
for degenerated bioprosthetic aortic valve: an updated meta-analysis comparing midterm outcomes. Catheter Cardiovasc Interv
2021;97:1481-8. DOI PubMed
11. Saleem S, Ullah W, Syed MA, et al. Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated
bioprosthetic aortic valve. Catheter Cardiovasc Interv 2021;98:940-7. DOI PubMed
12. Tarantini G, Dvir D, Tang GHL. Transcatheter aortic valve implantation in degenerated surgical aortic valves. EuroIntervention
2021;17:709-19. DOI PubMed
13. Edelman JJ, Khan JM, Rogers T, et al. Valve-in-valve TAVR: state-of-the-art review. Innovations (Phila) 2019;14:299-310. DOI
PubMed
14. Simonato M, Dvir D. Transcatheter aortic valve replacement in failed surgical valves. Heart 2019;105:s38-43. DOI PubMed
15. Duncan A, Moat N, Simonato M, et al. Outcomes following transcatheter aortic valve replacement for degenerative stentless versus
stented bioprostheses. JACC Cardiovasc Interv 2019;12:1256-63. DOI PubMed
16. Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following
transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J
2018;39:687-95. DOI PubMed
17. Alnasser S, Cheema AN, Simonato M, et al; Valve-in-Valve International Data Registry Investigators. Matched comparison of self-
expanding transcatheter heart valves for the treatment of failed aortic surgical bioprosthesis: insights from the valve-in-valve
international data registry (VIVID). Circ Cardiovasc Interv 2017;10:e004392. DOI PubMed
18. Seiffert M, Treede H, Schofer J, et al. Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve
implantations in failed surgical aortic bioprostheses. EuroIntervention 2018;14:e397-404. DOI PubMed
19. Francone M, Budde RPJ, Bremerich J, et al. CT and MR imaging prior to transcatheter aortic valve implantation: standardisation of
scanning protocols, measurements and reporting-a consensus document by the European Society of Cardiovascular Radiology (ESCR).
Eur Radiol 2020;30:2627-50. DOI PubMed PMC
20. Bapat V. Valve-in-valve apps: why and how they were developed and how to use them. EuroIntervention 2014;10 Suppl U:U44-51.
DOI PubMed
21. Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J Am Coll
Cardiol 2018;71:1513-24. DOI PubMed
22. Dvir D. Treatment of small surgical valves: clinical considerations for achieving optimal results in valve-in-valve procedures. JACC
Cardiovasc Interv 2015;8:2034-6. DOI PubMed
23. Rodés-Cabau J, Pibarot P, Suri RM, et al. Impact of aortic annulus size on valve hemodynamics and clinical outcomes after
transcatheter and surgical aortic valve replacement: insights from the PARTNER Trial. Circ Cardiovasc Interv 2014;7:701-11. DOI
PubMed
24. Ochiai T, Oakley L, Sekhon N, et al. Risk of coronary obstruction due to sinus sequestration in redo transcatheter aortic valve
replacement. JACC Cardiovasc Interv 2020;13:2617-27. DOI PubMed
25. Blanke P, Soon J, Dvir D, et al. Computed tomography assessment for transcatheter aortic valve in valve implantation: the vancouver
approach to predict anatomical risk for coronary obstruction and other considerations. J Cardiovasc Comput Tomogr 2016;10:491-9.
DOI PubMed
26. Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation,
device selection, protection, and treatment. Circ Cardiovasc Interv 2015;8:e002079. DOI PubMed
27. Mercanti F, Rosseel L, Neylon A, et al. Chimney stenting for coronary occlusion during TAVR: insights from the chimney registry.
JACC Cardiovasc Interv 2020;13:751-61. DOI PubMed
28. Romano V, Buzzatti N, Latib A, Colombo A, Montorfano M. Chimney technique for coronary obstruction after aortic valve in valve:
pros and cons. Eur Heart J Cardiovasc Imaging 2018;19:1194. DOI PubMed
29. Khan JM, Dvir D, Greenbaum AB, et al. Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter
aortic valve replacement: concept to first-in-human. JACC Cardiovasc Interv 2018;11:677-89. DOI PubMed PMC
30. Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet
laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv 2019;12:1240-52. DOI PubMed PMC
31. De Backer O, Søndergaard L. Is BASILICA the standard for preventing coronary obstruction in high-risk transcatheter aortic valve
replacement? JACC Cardiovasc Interv 2021;14:949-51. DOI PubMed